BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 23735359)

  • 1. Electrophysiological evaluation of atrioventricular conduction disturbances in transcatheter aortic valve implantation with Edwards SAPIEN prosthesis.
    Eksik A; Gul M; Uyarel H; Surgit O; Yildirim A; Uslu N; Aksu H; Turen S; Uzun F; Satılmısoglu H; Erol MK; Bakir I
    J Invasive Cardiol; 2013 Jun; 25(6):305-9. PubMed ID: 23735359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conduction disturbances and permanent cardiac pacing after transcatheter implantation of the CoreValve aortic bioprosthesis: initial single centre experience.
    Czerwińska K; Hryniewiecki T; Oręziak A; Dąbrowski M; Michałowska I; Witkowski A; Demkow M; Stępińska J; Orłowska Baranowska E; Rużyłło W
    Kardiol Pol; 2012; 70(2):121-8. PubMed ID: 22427074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of conduction disturbances after transcatheter implantation of an Edwards Sapien aortic valve prosthesis.
    Godin M; Eltchaninoff H; Furuta A; Tron C; Anselme F; Bejar K; Sanchez-Giron C; Bauer F; Litzler PY; Bessou JP; Cribier A
    Am J Cardiol; 2010 Sep; 106(5):707-12. PubMed ID: 20723650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence of transcatheter aortic valve implantation-related heart block in self-expandable Medtronic CoreValve and balloon-expandable Edwards valves.
    Liang M; Devlin G; Pasupati S
    J Invasive Cardiol; 2012 Apr; 24(4):173-6. PubMed ID: 22477754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of conduction disturbances after Edwards SAPIEN percutaneous valve implantation.
    Laynez A; Ben-Dor I; Barbash IM; Hauville C; Sardi G; Maluenda G; Xue Z; Satler LF; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2012 Oct; 110(8):1164-8. PubMed ID: 22770935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Edwards Sapien XT versus Lotus Valve Devices in Terms of Electrophysiological Study Parameters in Patients Undergoing TAVI.
    Eksik A; Yildirim A; Gul M; Aslan S; Tosu AR; Surgit O; Cakmak HA; Satilmisoglu MH; Akkaya E; Bakir I
    Pacing Clin Electrophysiol; 2016 Oct; 39(10):1132-1140. PubMed ID: 27418419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation.
    Binder RK; Webb JG; Toggweiler S; Freeman M; Barbanti M; Willson AB; Alhassan D; Hague CJ; Wood DA; Leipsic J
    JACC Cardiovasc Interv; 2013 May; 6(5):462-8. PubMed ID: 23702010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and predictors of left bundle branch block after transcatheter aortic valve implantation.
    Aktug Ö; Dohmen G; Brehmer K; Koos R; Altiok E; Deserno V; Herpertz R; Autschbach R; Marx N; Hoffmann R
    Int J Cardiol; 2012 Sep; 160(1):26-30. PubMed ID: 21458085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of incidence and predictors of left bundle branch block after transcatheter aortic valve implantation using the CoreValve versus the Edwards valve.
    Franzoni I; Latib A; Maisano F; Costopoulos C; Testa L; Figini F; Giannini F; Basavarajaiah S; Mussardo M; Slavich M; Taramasso M; Cioni M; Longoni M; Ferrarello S; Radinovic A; Sala S; Ajello S; Sticchi A; Giglio M; Agricola E; Chieffo A; Montorfano M; Alfieri O; Colombo A
    Am J Cardiol; 2013 Aug; 112(4):554-9. PubMed ID: 23726173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence, fate and consequences of ventricular conduction abnormalities after transcatheter aortic valve implantation.
    Houthuizen P; van der Boon RM; Urena M; Van Mieghem N; Brueren GB; Poels TT; Van Garsse LA; Rodés-Cabau J; Prinzen FW; de Jaegere P
    EuroIntervention; 2014 Feb; 9(10):1142-50. PubMed ID: 24273252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year follow-up of conduction disturbances following transcatheter aortic valve implantation.
    Salizzoni S; Anselmino M; Fornengo C; Giordana F; La Torre M; Moretti C; D'Amico M; Omedé P; Marra S; Rinaldi M; Gaita F
    J Cardiovasc Med (Hagerstown); 2015 Apr; 16(4):296-302. PubMed ID: 25719906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients without prolonged QRS after TAVI with CoreValve device do not experience high-degree atrio-ventricular block.
    Mouillet G; Lellouche N; Lim P; Meguro K; Yamamoto M; Deux JF; Monin JL; Bergoënd E; Dubois-Randé JL; Teiger E
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):882-7. PubMed ID: 22972678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrioventricular conduction disturbance characterization in transcatheter aortic valve implantation with the CoreValve prosthesis.
    Rubín JM; Avanzas P; del Valle R; Renilla A; Ríos E; Calvo D; Lozano I; Anguera I; Díaz-Molina B; Cequier A; Morís de la Tassa C
    Circ Cardiovasc Interv; 2011 Jun; 4(3):280-6. PubMed ID: 21540440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors for new-onset complete heart block after transcatheter aortic valve implantation.
    Bleiziffer S; Ruge H; Hörer J; Hutter A; Geisbüsch S; Brockmann G; Mazzitelli D; Bauernschmitt R; Lange R
    JACC Cardiovasc Interv; 2010 May; 3(5):524-30. PubMed ID: 20488409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and predictors of permanent pacemaker requirement after transcatheter aortic valve implantation with a self-expanding bioprosthesis.
    Ferreira ND; Caeiro D; Adão L; Oliveira M; Gonçalves H; Ribeiro J; Teixeira M; Albuquerque A; Primo J; Braga P; Simões L; Ribeiro VG
    Pacing Clin Electrophysiol; 2010 Nov; 33(11):1364-72. PubMed ID: 20723083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcatheter aortic valve implantation with a balloon-expandable valve.
    Urena M; Mok M; Serra V; Dumont E; Nombela-Franco L; DeLarochellière R; Doyle D; Igual A; Larose E; Amat-Santos I; Côté M; Cuéllar H; Pibarot P; de Jaegere P; Philippon F; Garcia del Blanco B; Rodés-Cabau J
    J Am Coll Cardiol; 2012 Oct; 60(18):1743-52. PubMed ID: 23040577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation with the Edwards SAPIEN-XT prosthesis.
    Durand E; Eltchaninoff H; Canville A; Bouhzam N; Godin M; Tron C; Rodriguez C; Litzler PY; Bauer F; Cribier A
    Am J Cardiol; 2015 Apr; 115(8):1116-22. PubMed ID: 25726383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the Pacemaker Rate After Transition From Edwards SAPIEN XT to SAPIEN 3 Transcatheter Aortic Valve Implantation: The Critical Role of Valve Implantation Height.
    De Torres-Alba F; Kaleschke G; Diller GP; Vormbrock J; Orwat S; Radke R; Reinke F; Fischer D; Reinecke H; Baumgartner H
    JACC Cardiovasc Interv; 2016 Apr; 9(8):805-813. PubMed ID: 27017367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter aortic valve replacement using the Edwards SAPIEN transcatheter heart valves.
    Huang PH; Eisenhauer AC
    Cardiol Clin; 2013 Aug; 31(3):337-50. PubMed ID: 23931098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conduction Abnormalities and Pacemaker Implantations After SAPIEN 3 Vs SAPIEN XT Prosthesis Aortic Valve Implantation.
    Husser O; Kessler T; Burgdorf C; Templin C; Pellegrini C; Schneider S; Kasel AM; Kastrati A; Schunkert H; Hengstenberg C
    Rev Esp Cardiol (Engl Ed); 2016 Feb; 69(2):141-8. PubMed ID: 26542175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.